Elong Power Stock Soars 666% Amid Share Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 02 2026
0mins
Should l Buy ELPW?
Source: stocktwits
- Share Offering Plan: Elong Power is offering 6,666,666 units, each consisting of one Class A ordinary share priced at $0.00016, attracting significant retail investor interest despite dilution concerns.
- Stock Price Surge: The company's stock skyrocketed by 666% in January 2023, contrasting sharply with a 92% decline in 2025, indicating strong market interest in its high-power battery technologies and investor optimism.
- Reverse Stock Split: In December, Elong Power announced a 16-for-1 reverse stock split, expected to reduce the total number of outstanding shares from 61.3 million to 3.8 million, aimed at increasing market value per share and improving shareholder structure.
- Retail Sentiment Surge: According to Stocktwits data, retail message volume for Elong Power surged by 12,900% over the past week, with user sentiment rising from 'bullish' to 'extremely bullish', reflecting strong expectations for the stock to potentially break the $30 mark.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ELPW?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ELPW
About ELPW
eLong Power Holding Ltd is a holding company principally engaged in the research and development, manufacturing, sales, and service of high-power lithium-ion batteries and related systems. The Company’s main businesses include the production of high-power lithium-ion batteries for electric vehicles and construction machinery, as well as large-capacity, long-cycle lithium-ion batteries for energy storage systems. The Company’s product and technology system covers battery cells, modules, system integration, and battery management system (BMS) development. The Company’s product portfolio includes lithium manganese oxide and lithium iron phosphate batteries and others, designed for high-power applications and energy storage scenarios.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
U.S. Stocks Rise in Morning Trade Amid Economic Slowdown
- Dow Jones Surge: The Dow Jones Industrial Average gained over 300 points on Friday, rising 0.68% to 46,995.67, indicating a positive market reaction to economic data that may boost investor confidence.
- NASDAQ and S&P 500 Performance: The NASDAQ rose 0.40% to 22,401.88, while the S&P 500 increased by 0.50% to 6,706.16, reflecting strong performances in tech and large-cap stocks, suggesting optimism about future growth.
- Economic Growth Slowdown: According to the Bureau of Economic Analysis, the GDP growth rate for Q4 2025 was revised down to 0.7% from an initial estimate of 1.4%, marking a sharp deceleration from the 4.4% growth pace in Q3, highlighting concerns about economic momentum.
- Commodity Market Fluctuations: Oil prices fell by 1.7% to $94.11, and gold dipped 0.2% to $5,118.00 on Friday, indicating that uncertainties about the economic outlook are impacting commodity prices, potentially leading investors to reassess risks.
See More
The Oncology Institute Reports Strong Q4 Results, Shares Surge
- Earnings Beat: The Oncology Institute reported a Q4 loss of 6 cents per share, outperforming the analyst consensus estimate of a 9-cent loss, indicating improvements in cost management and operational efficiency, which boosts market confidence in its future profitability.
- Sales Growth: The company achieved quarterly sales of $141.957 million, exceeding the analyst consensus of $139.775 million, reflecting positive progress in market demand and product promotion, thereby strengthening its market position in oncology treatment.
- Stock Surge: Shares of The Oncology Institute jumped 14.7% to $3.01 in pre-market trading, demonstrating a positive investor reaction to the financial results, which may attract more investor interest in its future developments.
- Increased Market Confidence: The better-than-expected performance not only enhances investor confidence but may also prompt analysts to reassess the company's long-term growth potential, potentially influencing future stock price movements and market performance.
See More
eLong Power Shares Surge 45.13% After Reverse Stock Split
- Reverse Stock Split Effective: eLong Power Holding Ltd. executed an 80-for-1 reverse stock split on Thursday, resulting in a 45.13% surge in after-hours trading to $5.21, despite a 14.20% drop to $3.59 during regular trading, indicating a positive market reaction to the split.
- Shareholder Meeting Decision: According to an SEC filing, the board approved the share consolidation on March 5 to ensure compliance with Nasdaq listing rules, aiming to maintain a closing bid price above $0.10, thereby enhancing market confidence.
- Significant Reduction in Shares: Following the split, eLong's outstanding shares decreased from approximately 63 million to about 790,000, with no substantial change in individual shareholder ownership percentages, potentially increasing the attractiveness of earnings per share.
- Market Performance Analysis: eLong Power has a market capitalization of $425.76 million, with a staggering 99.59% decline in stock price over the past 12 months, currently positioned near its 52-week low, reflecting a negative long-term outlook despite a short-term rebound due to the split.
See More
U.S. Stocks Decline Amid Weak Retail Sales Data
- Market Performance: U.S. stocks broadly declined during trading, with the S&P 500 falling approximately 1%, the Dow down 0.99% to 47,479.25, and the NASDAQ dropping 0.86% to 22,554.26, indicating market concerns over economic outlook.
- Retail Sales Data: U.S. retail sales fell by 0.2% month-over-month in January, missing market estimates of a 0.3% decline, reflecting weak consumer spending that could negatively impact economic growth.
- Sector Movements: While the overall market declined, energy stocks rose by 0.5%, contrasting with a 2.1% drop in financial stocks, indicating sector divergence that may influence investor asset allocation strategies.
- International Market Dynamics: European shares fell broadly, with the eurozone's STOXX 600 down 1.04%, while Asian markets mostly gained, suggesting varying performances across regions that could affect global investor confidence.
See More
Elong Power Announces Share Consolidation Plan
- Share Consolidation Ratio: Elong Power announced a share consolidation at a ratio of 1 for 80, effective March 12, 2026, aimed at ensuring compliance with Nasdaq listing rules by maintaining a closing bid price above $0.10.
- Shareholder Meeting Resolution: At the extraordinary general meeting on January 6, 2026, shareholders approved the implementation of share consolidations, allowing the board to execute multiple consolidations within two years, with a maximum cumulative ratio of 4000:1, providing flexibility in capital structure adjustments.
- Impact on Share Count: Following the consolidation, the company's outstanding shares will decrease from approximately 63 million to about 790,000, which, while not altering individual ownership percentages, is expected to enhance earnings per share and market perception, thereby boosting investor confidence.
- No Action Required by Shareholders: The share consolidation will occur automatically without requiring action from shareholders, and no fractional shares will be issued, ensuring that all shareholders receive full ordinary shares, thus simplifying the process and reducing operational complexity.
See More
Elong Power Announces Share Consolidation Plan
- Share Consolidation Ratio: Elong Power has announced a reverse split of its shares at a ratio of 1 for 80, aimed at complying with Nasdaq listing rules to maintain a closing bid price above $0.10, thereby enhancing market confidence.
- Shareholder Meeting Approval: At the extraordinary general meeting on January 6, 2026, shareholders approved the consolidation plan, empowering the board to execute multiple consolidations within two years at a maximum ratio of 4000:1, reflecting strong shareholder support for corporate governance.
- Impact on Share Count: Post-consolidation, the company's outstanding shares will decrease from approximately 63 million to about 790,000, which, while maintaining shareholders' percentage ownership, is expected to improve earnings per share and market liquidity, thus attracting more investors.
- Trading Adjustment Notice: The reverse split will take effect on March 12, 2026, with the company's shares trading on Nasdaq under a new CUSIP number, ensuring a smooth transition for investors to the new share structure.
See More
U.S. Stocks Rise in Morning Trade Amid Economic Slowdown
- Dow Jones Surge: The Dow Jones Industrial Average gained over 300 points on Friday, rising 0.68% to 46,995.67, indicating a positive market reaction to economic data that may boost investor confidence.
- NASDAQ and S&P 500 Performance: The NASDAQ rose 0.40% to 22,401.88, while the S&P 500 increased by 0.50% to 6,706.16, reflecting strong performances in tech and large-cap stocks, suggesting optimism about future growth.
- Economic Growth Slowdown: According to the Bureau of Economic Analysis, the GDP growth rate for Q4 2025 was revised down to 0.7% from an initial estimate of 1.4%, marking a sharp deceleration from the 4.4% growth pace in Q3, highlighting concerns about economic momentum.
- Commodity Market Fluctuations: Oil prices fell by 1.7% to $94.11, and gold dipped 0.2% to $5,118.00 on Friday, indicating that uncertainties about the economic outlook are impacting commodity prices, potentially leading investors to reassess risks.
See More
The Oncology Institute Reports Strong Q4 Results, Shares Surge
- Earnings Beat: The Oncology Institute reported a Q4 loss of 6 cents per share, outperforming the analyst consensus estimate of a 9-cent loss, indicating improvements in cost management and operational efficiency, which boosts market confidence in its future profitability.
- Sales Growth: The company achieved quarterly sales of $141.957 million, exceeding the analyst consensus of $139.775 million, reflecting positive progress in market demand and product promotion, thereby strengthening its market position in oncology treatment.
- Stock Surge: Shares of The Oncology Institute jumped 14.7% to $3.01 in pre-market trading, demonstrating a positive investor reaction to the financial results, which may attract more investor interest in its future developments.
- Increased Market Confidence: The better-than-expected performance not only enhances investor confidence but may also prompt analysts to reassess the company's long-term growth potential, potentially influencing future stock price movements and market performance.
See More
eLong Power Shares Surge 45.13% After Reverse Stock Split
- Reverse Stock Split Effective: eLong Power Holding Ltd. executed an 80-for-1 reverse stock split on Thursday, resulting in a 45.13% surge in after-hours trading to $5.21, despite a 14.20% drop to $3.59 during regular trading, indicating a positive market reaction to the split.
- Shareholder Meeting Decision: According to an SEC filing, the board approved the share consolidation on March 5 to ensure compliance with Nasdaq listing rules, aiming to maintain a closing bid price above $0.10, thereby enhancing market confidence.
- Significant Reduction in Shares: Following the split, eLong's outstanding shares decreased from approximately 63 million to about 790,000, with no substantial change in individual shareholder ownership percentages, potentially increasing the attractiveness of earnings per share.
- Market Performance Analysis: eLong Power has a market capitalization of $425.76 million, with a staggering 99.59% decline in stock price over the past 12 months, currently positioned near its 52-week low, reflecting a negative long-term outlook despite a short-term rebound due to the split.
See More
U.S. Stocks Decline Amid Weak Retail Sales Data
- Market Performance: U.S. stocks broadly declined during trading, with the S&P 500 falling approximately 1%, the Dow down 0.99% to 47,479.25, and the NASDAQ dropping 0.86% to 22,554.26, indicating market concerns over economic outlook.
- Retail Sales Data: U.S. retail sales fell by 0.2% month-over-month in January, missing market estimates of a 0.3% decline, reflecting weak consumer spending that could negatively impact economic growth.
- Sector Movements: While the overall market declined, energy stocks rose by 0.5%, contrasting with a 2.1% drop in financial stocks, indicating sector divergence that may influence investor asset allocation strategies.
- International Market Dynamics: European shares fell broadly, with the eurozone's STOXX 600 down 1.04%, while Asian markets mostly gained, suggesting varying performances across regions that could affect global investor confidence.
See More
Elong Power Announces Share Consolidation Plan
- Share Consolidation Ratio: Elong Power announced a share consolidation at a ratio of 1 for 80, effective March 12, 2026, aimed at ensuring compliance with Nasdaq listing rules by maintaining a closing bid price above $0.10.
- Shareholder Meeting Resolution: At the extraordinary general meeting on January 6, 2026, shareholders approved the implementation of share consolidations, allowing the board to execute multiple consolidations within two years, with a maximum cumulative ratio of 4000:1, providing flexibility in capital structure adjustments.
- Impact on Share Count: Following the consolidation, the company's outstanding shares will decrease from approximately 63 million to about 790,000, which, while not altering individual ownership percentages, is expected to enhance earnings per share and market perception, thereby boosting investor confidence.
- No Action Required by Shareholders: The share consolidation will occur automatically without requiring action from shareholders, and no fractional shares will be issued, ensuring that all shareholders receive full ordinary shares, thus simplifying the process and reducing operational complexity.
See More
Elong Power Announces Share Consolidation Plan
- Share Consolidation Ratio: Elong Power has announced a reverse split of its shares at a ratio of 1 for 80, aimed at complying with Nasdaq listing rules to maintain a closing bid price above $0.10, thereby enhancing market confidence.
- Shareholder Meeting Approval: At the extraordinary general meeting on January 6, 2026, shareholders approved the consolidation plan, empowering the board to execute multiple consolidations within two years at a maximum ratio of 4000:1, reflecting strong shareholder support for corporate governance.
- Impact on Share Count: Post-consolidation, the company's outstanding shares will decrease from approximately 63 million to about 790,000, which, while maintaining shareholders' percentage ownership, is expected to improve earnings per share and market liquidity, thus attracting more investors.
- Trading Adjustment Notice: The reverse split will take effect on March 12, 2026, with the company's shares trading on Nasdaq under a new CUSIP number, ensuring a smooth transition for investors to the new share structure.
See More
